Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Impact of Ranolazine on Coronary Microcirculatory Resistance

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2015 by University of New Mexico
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Bina Ahmed, University of New Mexico
ClinicalTrials.gov Identifier:
NCT01815957
First received: March 19, 2013
Last updated: June 1, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)